Naturally Occurring Plectranthus-derived Diterpenes with Antitumoral Activities.

Abstract:

:The study of natural sources such as plants, microorganisms and marine organisms has developed interest among the scientific community in recent years for their extensive and diverse chemical composition and consequent biological potential. The search for antitumor compounds is among the lead causes that justify phytochemical studies. Although some natural products have served as FDA approved chemotherapeutic agents, there is still a demand for the search of compounds with those characteristics. The Plectranthus genus has long been used in traditional medicine, and scientific studies have already proven its undeniable value as a source of bioactive compounds. Diterpenes are the most prominent biologically active group of secondary metabolites present in this genus. In particular, abietane diterpenes have long been studied for their biological activities, namely their anti-tumoral potential. In this review, abietane diterpenes isolated from Plectranthus genus with antiproliferative, antitumoral or cytotoxic potential are reported. In addition, a correlation between this subclass of diterpenes with their mechanisms of cell death has been discussed.

journal_name

Curr Pharm Des

authors

Garcia C,Teodósio C,Oliveira C,Oliveira C,Díaz-Lanza A,Reis C,Duarte N,Rijo P

doi

10.2174/1381612825666190115144241

subject

Has Abstract

pub_date

2018-01-01 00:00:00

pages

4207-4236

issue

36

eissn

1381-6128

issn

1873-4286

pii

CPD-EPUB-95802

journal_volume

24

pub_type

杂志文章,评审
  • Gene Delivery with Organic Electronic Biomaterials.

    abstract::Gene therapy may be capable of treating a variety of diseases, a prerequisite of which is the successful delivery of polynucleic acids (e.g., DNA, RNA) to a patient's cells. Delivery can be achieved technologically (e.g., using electroporation), using viruses (natural gene delivery vectors) or non-viral vectors (e.g.,...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666170710124137

    authors: Clancy KFA,Hardy JG

    更新日期:2017-01-01 00:00:00

  • Current, New and Future Therapeutic Targets in Inflammatory Bowel Disease: A Systematic Review.

    abstract::Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic relapsing conditions resulting from immune system activity in a genetically predisposed individual. IBD is based on progressive damage to the inflamed gut tissue. As its pathogenesis remains unknown, recent accumu...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200406081920

    authors: Alimohammadi N,Koosha F,Rafeian-Kopaei M

    更新日期:2020-01-01 00:00:00

  • Angiotensin-converting enzyme inhibitors in veterinary medicine.

    abstract::Angiotensin-converting enzyme (ACE) inhibitors represent one of the most commonly used categories of drugs in canine and feline medicine. ACE inhibitors currently approved for use in veterinary medicine are benazepril, enalapril, imidapril and ramipril. They are all pro-drugs administered by oral route. A physiologica...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161207780618830

    authors: Lefebvre HP,Brown SA,Chetboul V,King JN,Pouchelon JL,Toutain PL

    更新日期:2007-01-01 00:00:00

  • Pharmacological Treatments for Fragile X Syndrome Based on Synaptic Dysfunction.

    abstract:BACKGROUND:Fragile X syndrome (FXS) is the most common form of monogenic hereditary cognitive impairment, including intellectual disability, autism, hyperactivity, and epilepsy. METHODS:This article reviews the literature pertaining to the role of synaptic dysfunction in FXS. RESULTS:In FXS, synaptic dysfunction alte...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666191102165206

    authors: Telias M

    更新日期:2019-01-01 00:00:00

  • Antibodies and their fragments as anti-cancer agents.

    abstract::The recent developments in the field of recombinant DNA, protein engineering and cancer biology, have let us gain insight into many cancer-related mechanisms. Moreover, novel techniques have facilitated tools allowing unique distinction between malignantly transformed cells, to regular ones. This understanding has pav...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206775201983

    authors: Schaedel O,Reiter Y

    更新日期:2006-01-01 00:00:00

  • Solid Lipid Nanoparticles: A Promising Nanomaterial in Drug Delivery.

    abstract::The solid lipid nanoparticles (SLNs) usually consists of active drug molecules along with solid lipids, surfactants, and/or co-surfactants. They possess some potential features such as nano-size, surface with a free functional group to attach ligands, and as well they prove safe homing for both lipophilic as well as h...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666190903155321

    authors: Rajpoot K

    更新日期:2019-01-01 00:00:00

  • Novel targets for cardiac antiarrhythmic drug development.

    abstract::Cardiac arrhythmias remain a major source of morbidity and mortality in developed countries. Antiarrhythmic drug therapy was traditionally the mainstay of cardiac arrhythmia treatment; however, drug therapy of cardiac arrhythmias has been plagued by incomplete efficacy and by potentially serious adverse reactions, of ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612054021051

    authors: Hesketh JC,Herrera D,Zicha S,Nattel S

    更新日期:2005-01-01 00:00:00

  • The urokinase receptor in hematopoietic stem cells mobilization.

    abstract::The receptor for urokinase plasminogen activator (uPAR) is required in hematopoietic stem/progenitor cells (HSC, HPC) mobilization in the mouse. Indeed, uPAR Ko mice are deficient both in retention and mobilization of HSC and HPC, because uPAR causes their retention in the BM through its interaction with the α4β1 inte...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/138161211796718206

    authors: Blasi F

    更新日期:2011-01-01 00:00:00

  • Targeting Kinases in Cancer Therapies: Adverse Effects on Blood Platelets.

    abstract::The development of targeted therapy drugs acting on tumor growth and progression is greatly expanding these last years. Among them kinase inhibitors have a prominent position and have demonstrated efficacy and clinical benefits in solid and hematologic malignancies. Compared to conventional systemic cytotoxic chemothe...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160226132630

    authors: Levade M,Severin S,Gratacap MP,Ysebaert L,Payrastre B

    更新日期:2016-01-01 00:00:00

  • Antiepileptic Drugs Based on the α-Substituted Amide Group Pharmacophore: From Chemical Crystallography to Molecular Pharmaceutics.

    abstract::The antiepileptic activity of α-substituted acetamides, lactams, and cyclic imides has been known for over six decades. We recently proposed an α-substituted amide group as the minimum pharmacophore responsible for inhibition of neuronal nicotinic acetylcholine receptors by these compounds, with the implication that i...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160722095748

    authors: Krivoshein AV

    更新日期:2016-01-01 00:00:00

  • Radiolabelled peptides and monoclonal antibodies for therapy decision making in inflammatory diseases.

    abstract::Radiolabelled peptides and monoclonal antibodies are an emerging class of radiopharmaceuticals for imaging inflammation with clinical implications for several chronic inflammatory disorders for diagnosis, therapy decision making and follow up. In the last decades, a number of novel monoclonal antibodies and peptides h...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208785777414

    authors: Malviya G,Signore A,Laganà B,Dierckx RA

    更新日期:2008-01-01 00:00:00

  • State of the art and perspectives in food allergy (part II): therapy.

    abstract::Currently management of food allergy is mainly based on absolute avoidance of the offending food(s) and the use of rescue medication. However, the risk of severe or life-threatening reactions due to inadvertent exposure, nutritional imbalance and social isolation raises the demand of disease-modifying treatments. The ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990045

    authors: Sabato V,Faber M,Van Gasse A,Hagendorens MM,Leysen J,Bridts CH,De Clerck LS,Ebo DG

    更新日期:2014-01-01 00:00:00

  • Optimization of cardiac metabolism in heart failure.

    abstract::The derangement of the cardiac energy substrate metabolism plays a key role in the pathogenesis of heart failure. The utilization of non-carbohydrate substrates, such as fatty acids, is the predominant metabolic pathway in the normal heart, because this provides the highest energy yield per molecule of substrate metab...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211798357773

    authors: Nagoshi T,Yoshimura M,Rosano GM,Lopaschuk GD,Mochizuki S

    更新日期:2011-12-01 00:00:00

  • Angiotensin II and Abdominal Aortic Aneurysms: An update.

    abstract::Abdominal aortic aneurysm (AAA) is a devastating disease associated with high prevalence of death due to aortic rupture. Currently the therapy is restricted to surgical procedures to prevent aortic rupture, which in turn has a risk for postoperative mortality. There are no proven pharmacological therapies available to...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150826093318

    authors: Liu J,Daugherty A,Lu H

    更新日期:2015-01-01 00:00:00

  • Pharmacological management of acutely agitated schizophrenic patients.

    abstract::Agitation is commonly seen in acute schizophrenic patients and core symptoms include a wide range of symptom. It requires rapid and effective treatment approaches in order to protect patient and caregiver from potential injury. Clinician's decision of pharmacological treatment should be individualized to the needs and...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612054367472

    authors: San L,Arranz B,Escobar R

    更新日期:2005-01-01 00:00:00

  • Perinatal gene transfer to the liver.

    abstract::The liver acts as a host to many functions hence raising the possibility that any one may be compromised by a single gene defect. Inherited or de novo mutations in these genes may result in relatively mild diseases or be so devastating that death within the first weeks or months of life is inevitable. Some diseases ca...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211797247541

    authors: McKay TR,Rahim AA,Buckley SM,Ward NJ,Chan JK,Howe SJ,Waddington SN

    更新日期:2011-01-01 00:00:00

  • Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

    abstract::Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a non-flavonoid polyphenol that may be present in a limited number of foodstuffs such as grapes and red wine. Resveratrol has been reported to exert a plethora of health benefits through many different mechanisms of action. This versatility and presence in the human di...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990407

    authors: Tomé-Carneiro J,Larrosa M,González-Sarrías A,Tomás-Barberán FA,García-Conesa MT,Espín JC

    更新日期:2013-01-01 00:00:00

  • Recent development and application of virtual screening in drug discovery: an overview.

    abstract::Virtual screening, especially the structure-based virtual screening, has emerged as a reliable, cost-effective and time-saving technique for the discovery of lead compounds. Here, the basic ideas and computational tools for virtual screening have been briefly introduced, and emphasis is placed on aspects of recent dev...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612043452721

    authors: Hou T,Xu X

    更新日期:2004-01-01 00:00:00

  • Viral proteases as targets for drug design.

    abstract::In order to productively infect a host, viruses must enter the cell and force host cell replication mechanisms to produce new infectious virus particles. The success of this process unfortunately results in disease progression and, in the case of infection with many viral species, may cause mortality. The discoveries ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612811319060013

    authors: Skoreński M,Sieńczyk M

    更新日期:2013-01-01 00:00:00

  • Insulin secretagogues, sulfonylurea receptors and K(ATP) channels.

    abstract::ATP-sensitive K+ channels, termed K(ATP) channels, provide a link between cellular metabolism and membrane electrical activity in a variety of tissues. Channel isoforms have been identified and are targets for compounds that both stimulate and inhibit their activity resulting in membrane hyperpolarization and depolari...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612054546879

    authors: Bryan J,Crane A,Vila-Carriles WH,Babenko AP,Aguilar-Bryan L

    更新日期:2005-01-01 00:00:00

  • Recent progress in work on PGD2 antagonists for drugs targeting allergic diseases.

    abstract::Prostaglandin (PG) D(2), the major cyclooxygenase metabolite generated from immunologically stimulated mast cells, is thought to contribute to the pathogenesis of allergic diseases due to its various inflammatory effects. However, the lack of PGD(2) (DP) receptor antagonists has limited the study of its essential role...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612043382864

    authors: Mitsumori S

    更新日期:2004-01-01 00:00:00

  • Gold Nanoparticles- Boon in Cancer Theranostics.

    abstract:BACKGROUND:Cancer is the world's second-largest cause of death, with an estimated 9.6 million fatalities in 2018. Malignant tumour (cancer) is caused by a mixture of genetic modifications due to the environmental variables that tend to activate or inactivate different genes, ultimately resulting in neoplastic transform...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200701151403

    authors: Jindal M,Nagpal M,Singh M,Aggarwal G,Dhingra GA

    更新日期:2020-01-01 00:00:00

  • Therapeutic applications of human heme oxygenase gene transfer and gene therapy.

    abstract::The search for methods to control physiological levels of carbon monoxide (CO), a vasoactive molecule, and bilibrubin, an antioxidant, have improved our understanding of the protective role of heme oxygenase (HO) against oxidative injury. HO activity can assist other antioxidant systems in diminishing the overall prod...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612033453758

    authors: Abraham NG

    更新日期:2003-01-01 00:00:00

  • Appreciation of medical treatments through confidence intervals.

    abstract::The typical way of judging about either the efficacy of a new treatment or, on the contrary, the damage of a pollutant agent is through a test of hypothesis having its ineffectiveness as null hypothesis. This is the typical operational field of Kolmogorov's statistical framework where wastes of data (for instance non ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161207780765891

    authors: Apolloni B,Bassis S,Gaito S,Malchiodi D

    更新日期:2007-01-01 00:00:00

  • Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention.

    abstract::In the third millennium preventive medicine is becoming a corner stone in our concept of health. Colorectal cancer (CRC) fits the criteria of a disease suitable for prevention interventions. It is a prevalent disease that is associated with considerable mortality and morbidity rates, with more than 1,000,000 new cases...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161207781368783

    authors: Boursi B,Arber N

    更新日期:2007-01-01 00:00:00

  • Treatment of disorders characterized by reversible airway obstruction in childhood: are anti-cholinergic agents the answer?

    abstract::Release of acetylcholine from parasympathetic nerves in the airways activates postjunctional muscarinic receptors present on smooth muscle, submucosal glands and blood vessels. This triggers bronchoconstriction, muscle hypertrophy, mucus secretion, and vasodilatation, respectively. The release of acetylcholine from pa...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612811209023061

    authors: Quizon A,Colin AA,Pelosi U,Rossi GA

    更新日期:2012-01-01 00:00:00

  • Antibiotics Associated Disorders and Post-biotics Induced Rescue in Gut Health.

    abstract::The gut microbiota plays significant roles in the human body during all spheres' of life and influences innate immunity, promotes granulocyte signaling and provides resistance during pathogenic colonization of the gut; crucial for a healthy life. Antibiotics directly affect the gut microbiota that consequently alters ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612824666171227221731

    authors: Paul D,Manna S,Mandal SM

    更新日期:2018-01-01 00:00:00

  • Calcium Pattern Assessment in Patients with Severe Aortic Stenosis Via the Chou's 5-Steps Rule.

    abstract:BACKGROUND:Progression of aortic valve calcifications (AVC) leads to aortic valve stenosis (AS). Importantly, the AVC degree has a great impact on AS progression, treatment selection and outcomes. Methods of AVC assessment do not provide accurate quantitative evaluation and analysis of calcium distribution and depositi...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612825666190930101258

    authors: Wiktorowicz A,Wit A,Dziewierz A,Rzeszutko L,Dudek D,Kleczynski P

    更新日期:2019-01-01 00:00:00

  • The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents.

    abstract::Inhibition of carbonic anhydrase (CA, EC 4.2.1.1) isoforms present in the eyes (CA I, II, IV and XII), with sulfonamides such as acetazolamide, methazolamide, ethoxzolamide and dichlorophenamide, is still widely used for the systemic treatment of glaucoma. The mechanism of action of these drugs consists in inhibition ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208783877866

    authors: Mincione F,Scozzafava A,Supuran CT

    更新日期:2008-01-01 00:00:00

  • Writers and Erasers of Histone Lysine methylation with Clinically Applied Modulators: Promising Target for Cancer Therapy.

    abstract::Histone lysine methylation can be modified by various writers and erasers. Different from other epigenetic modifications, mono-, di, and tri- methylation distinctly modulate chromatin structure and thereby contribute to the regulation of DNA-based nuclear processes such as transcription, replication and repair on thei...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160715125417

    authors: Zheng YC,Ma JL,Liu Y,Liu HM

    更新日期:2016-01-01 00:00:00